Maharashtra: Government-Run Blood Banks Slapped Rs 12.72 Lakh In Fines For Neglecting Daily Stock Updates, Reveals RTI Inquiry

Mumbai: The State Blood Transfusion Council imposed a fine of over Rs 12,72,000 on 93 government-run blood banks between December 2022 to April 2023 for not updating the daily blood stock at MahaSBTC and e-raktkosh portal.

The data was revealed through a Right To Information (RTI) filed by activist Chetan Kothari seeking data regarding penalties imposed on blood banks in the last five months. As per the RTI, RN Cooper blood banks tops the list of penalties in terms of violation. Out of a total 121 days, the blood bank has uploaded its blood stock on e-raktkosh only for 25 days.

“The daily stock on e-raktkosh has not been updated 11 times in December 2022, followed by 22 times in January 2023, six times in February, 27 times in March and 30 days in April. All these clearly show that blood banks have not taken GR seriously,” said Kothari.

The public health department had released a government resolution (GR) on December 2 stating that if banks are charging processing fee in excess of the amount stipulated by the National Blood Transfusion Council (NBTC), a penalty of five times the extra processing fee will be levied on the bank.

A senior blood transfusion officer said that often the families of the patients are least aware of the availability of the blood at blood banks. In view of this, the government created the e-blood bank website on which blood banks of all the states have to upload information about their stock. “The basic objective is that whenever a patient needs blood and there is no blood in the blood bank of the hospital, then they can go to thee-blood bank and search in which blood bank the blood is available,” he said.

 

Related Posts

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

The issue came up for discussions during the visit of Commerce Secretary Rajesh Agarwal to Buenos Aires this week. Argentina has committed to reduce barriers to facilitate the entry of…

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

The regulator had found that medicines were stored directly on the floor and flagged deficiencies in procedures for handling expired medicines.   The Maharashtra Food and Drug Administration has cancelled…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

Six fake doctors arrested in Hyderabad

Six fake doctors arrested in Hyderabad